Assessment of hepatic fibrosis: What is the role of non-invasive markers in 2003?;Evaluation de la fibrose hépatíque: Quelle place pour les marqueurs non invasifs en 2003?

Gastroenterologie Clinique et Biologique

Volumn 27, Issue 4, 2003, Pages 367-370

  Mallat, Ariane ^a   Dhumeaux, Daniel ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; ANTIFIBROTIC AGENT; ANTIVIRUS AGENT; APOLIPOPROTEIN A; BILIRUBIN; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; HAPTOGLOBIN; HYALURONIC ACID; IMMUNOGLOBULIN; INTERFERON;

DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; EDITORIAL; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LIVER BIOPSY; LIVER FIBROSIS; MEDICAL ASSESSMENT; PREDICTION; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; TREATMENT INDICATION; BIOPSY; DIFFERENTIAL DIAGNOSIS; LIVER CIRRHOSIS; PATHOLOGY;

BIOLOGICAL MARKERS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; HUMANS; LIVER CIRRHOSIS;

EID: 0037844666     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (31)

1. Conférence de consensus. Traitement de l'hépatite C. Gastroenterol Clin Biol 2002;26:B303-20.
2. Trinchet JC. Histoire naturelle de l'infection par le virus de l'hépatite C. Gastroenterol Clin Biol 2002;26:B144-53.
3. Rosenbaum J, Mallat A, Mavier P. La fibrose hépatique, une « Itopathie »? Med Sci 1994;12:1245-52.
4. Friedman SL. Liver fibrosis - from bench to bedside. J Hepatol 2003;38:S38-53.
5. Geho KA, Herlong HF, Torhenson MS, Ghanem KG, El-Kamary SS, Sulkowski M, et al. Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 2002;36(Suppl2):S161-72.
6. National Institutes of Health consensus development conference statement: Management of hepatitis C: 2002 June 10-12, 2002. Hepatology 2003;36:S3-15.
7. Deugnier Y. Intérêt de la biopsie hépatique dans la prise en charge des malades ayant une infection chronique par le virus de l'hépatite C. Gastroenterol Clin Biol 1997;21:S51-6.
8. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994;20:15-20.
9. Chevallier M, Guerret S, Chossegros P, Gerard F, Grimaud JA. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 1994;20:349-55.
10. Pilette C, Croquet V, Vuillemin E, Oberti F, Calès P. Diagnostic précoce et non invasif de la cirrhose du foie. Gastroenterol Clin Biol 1999;23:557-65.
11. Nord HJ. Biopsy diagnosis of cirrhosis: blind percutaneous versus guided direct vision techniques. A review. Gastrointest endosc 1982;28:10-2.
12. Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97: 2614-8.
13. Holund B, Poulsen H, Schlichting P. Reproducibility of liver biopsy diagnosis in relation to the size of the specimen. Scand J Gastroenterol 1980;15:329-35.
14. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000;32:477-81.
15. Nousbaum JB. Place de la ponction-biopsie hépatique dans la prise en charge de l'hépatite chronique C. Gastroenterol Clin Biol 2002;26: B168-79.
16. Guechot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J. Diagnostic accuracy of hyaluronan and type III procollagen aminoterminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem 1996;42:558-63.
17. Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aube C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997;113:1609-16.
18. McHutchison JG, Blatt LM, de Medina M, Craig JR, Conrad A, Schiff ER, et al. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol 2000;15:945-51.
19. Tran A, Hastier P, Barjoan EM, Demuth N, Pradier C, Saint-Paul MC, et al. Non invasive prediction of severe fibrosis in patients with alcoholic liver disease. Gastroenterol Clin Biol 2000;24:626-30.
20. Croquet V, Vuillemin E, Ternisien C, Pilette C, Oberti F, Gallois Y, et al. Prothrombin index is an indirect marker of severe liver fibrosis. Eur J Gastroenterol Hepatol 2002;14:1133-41.
21. Patel K, Lajoie A, Heaton S, Pianko S, Behling CA, Bylund D, et al. Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C. J Gastroenterol Hepatol 2003;18:253-7.
22. Dienstag J. The role of liver biopsy in chronic hepatitis C. Hepatology 2002;32(Suppl 2):S153-60.
23. Bonacini M, Hadi G, Govindarajan S, Lindsay KL. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1997;92:1302-4.
24. Saadeh S, Cammell G, Carey WD, Younossi Z, Barnes D, Easley K. The role of liver biopsy in chronic hepatitis C. Hepatology 2001;33:196-200.
25. Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357: 1069-75.
26. Poynard T, Imbert-Bismut F, Ratziu V, Chevret S, Jardel C, Moussalli J, et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat 2002;9:128-33.
27. Rossi E, Adams L, Prins A, Bulsara M, De Boer B, Garas G, et al. Validation of the Fibrotest biochemicalmarkers score in assessing liver fibrosis in hepatitis C Patients. Clin Chem 2003;49:450-4.
28. Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002;36: 986-92.
29. Calès P, Oberti F, Rousselet MC, Gallois Y. Peut-on se passer de la ponction biopsie hépatique pour évaluer le degré de fibrose hépatique cliniquement significative? (résumé). Gastroenterol Clin Biol 2002;26: A135.
30. Paradis V, Bonvoust F, Dargere D, Ratziu V, Poynard T, Bedossa P. Etude du protéome sérique dans les hépatopathies chroniques virales C par la méthode du SELDI-TOF protein chip: identifications de nouveaux marqueurs non invasifs de fibrose (résumé). Gastroenterol Clin Biol 2002;26 (Suppl):764.
31. Patel K, Gordon SC, Smith K, McHutchison JG. A non invasive panel of serum fibrosis markers can reliably dfifferentiate hepatitis C patients with minimal fibrosis from those with fibrosis F2-F4 (abstract). Hepatology 2002;36:A770.